Literature DB >> 34649180

Inflammation mediates depression and generalized anxiety symptoms predicting executive function impairment after 18 years.

Nur Hani Zainal1, Michelle G Newman2.   

Abstract

INTRODUCTION: Scar theories propose that elevated depression and anxiety can predispose people to future decreased executive function (EF) via heightened inflammation across decades. However, more longitudinal (versus cross-sectional) research on this topic is needed.
OBJECTIVE: We thus investigated if increased major depressive disorder (MDD), generalized anxiety disorder (GAD), and panic disorder (PD) severity predicted EF decrement 18 years later via heightened inflammation.
METHOD: Community-dwelling adults participated in this study. Time 1 (T1) MDD, GAD, and PD severity (Composite International Diagnostic Interview-Short Form), T2 inflammation (interleukin-6, C-reactive protein, and fibrinogen blood levels concentration), and T2 and T3 EF (Brief Test of Adult Cognition by Telephone) were measured. The waves of assessment were spaced approximately 9 years apart. Structural equation modeling was conducted.
RESULTS: Higher T1 MDD and GAD (but not PD) severity forecasted elevated T2 inflammation (Cohen's d = 0.116-0.758). Greater T2 inflammation level predicted lower T3 EF following 9 years (d = -0.782--0.636). The T1 MDD-T3 EF and T1 GAD-T3 EF negative associations were mediated by T2 inflammation, and explained 38% and 19% of the relations, respectively. Direct effects of higher T1 GAD and MDD predicting lower T3 EF were also observed (d = -0.585--0.560). Significant effects remained after controlling for socio-demographic, lifestyle, medication use, various illness variables across time, and T2 EF.
CONCLUSIONS: Inflammation may be a mechanism explaining the T1 MDD-T3 EF and T1 GAD-T3 EF relations. Treatments that target inflammation, worry, and/or depression may prevent future EF decline.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affective neuroscience; Executive functioning; Generalized anxiety disorder; Longitudinal; Major depressive disorder; Mediation; Panic disorder; Worry

Mesh:

Year:  2021        PMID: 34649180      PMCID: PMC8603378          DOI: 10.1016/j.jad.2021.08.077

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  74 in total

Review 1.  Monotonicity of effect sizes: Questioning kappa-squared as mediation effect size measure.

Authors:  Zhonglin Wen; Xitao Fan
Journal:  Psychol Methods       Date:  2015-02-09

2.  Executive function and other cognitive deficits are distal risk factors of generalized anxiety disorder 9 years later.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  Psychol Med       Date:  2017-12-11       Impact factor: 7.723

Review 3.  Stress- and allostasis-induced brain plasticity.

Authors:  Bruce S McEwen; Peter J Gianaros
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

4.  Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study.

Authors:  Mary A Whooley; Catherine M Caska; Bethany E Hendrickson; Meghan A Rourke; Joseph Ho; Sadia Ali
Journal:  Biol Psychiatry       Date:  2007-04-16       Impact factor: 13.382

5.  Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition.

Authors:  Karen A Matthews; Laura L Schott; Joyce Bromberger; Jill Cyranowski; Susan A Everson-Rose; Mary Fran Sowers
Journal:  Psychosom Med       Date:  2007-02-08       Impact factor: 4.312

6.  High-sensitivity C-reactive protein and cognitive decline: the English Longitudinal Study of Ageing.

Authors:  Fanfan Zheng; Wuxiang Xie
Journal:  Psychol Med       Date:  2017-11-07       Impact factor: 7.723

7.  Childhood socioeconomic status and inflammation: Psychological moderators among Black and White Americans.

Authors:  Jennifer Morozink Boylan; Jenny M Cundiff; Thomas E Fuller-Rowell; Carol D Ryff
Journal:  Health Psychol       Date:  2020-03-26       Impact factor: 4.267

Review 8.  Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches.

Authors:  Hannah R Snyder; Akira Miyake; Benjamin L Hankin
Journal:  Front Psychol       Date:  2015-03-26

9.  Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies.

Authors:  Steven Bradburn; Jane Sarginson; Christopher A Murgatroyd
Journal:  Front Aging Neurosci       Date:  2018-01-08       Impact factor: 5.750

Review 10.  Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.

Authors:  Manish K Jha; Madhukar H Trivedi
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

View more
  4 in total

1.  Negative correlation between IL-1β, IL-12 and TNF-γ, and cortisol levels in patients with panic disorder.

Authors:  Ana Belén Fernández-Serrano; Francisco José Moya-Faz; Cesar Augusto Giner Alegría; Juan Carlos Fernández Rodríguez
Journal:  Brain Behav       Date:  2022-05-19       Impact factor: 3.405

2.  Life Satisfaction Prevents Decline in Working Memory, Spatial Cognition, and Processing Speed: Latent Change Score Analyses Across 23 Years.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  Eur Psychiatry       Date:  2022-04-19       Impact factor: 7.156

3.  Depression and anxiety of medical students at Kunming Medical University during COVID-19: A cross-sectional survey.

Authors:  Ying Guo; Shunda Li; Lanchun Zhang; Qun Xuan; Liu He; Qingyan Ye; Jiaqing Ma; Li Peng; Yunxia Xiong; Jianyu Yang; Haofei Yu; Jianping Xie; Heng Shao; Yun Yuan
Journal:  Front Public Health       Date:  2022-09-07

4.  Exploring the relationship between ADHD, its common comorbidities, and their relationship to organizational skills.

Authors:  Guillaume Durand; Ioana-Smarandita Arbone
Journal:  PeerJ       Date:  2022-01-20       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.